The aim of this study was to assess the prevalence and the prognostic value of ventricular late potentials in apparently healthy top-level athletes with ventricular arrhythmias, and the effect of physiological myocardial hypertrophy (athlete's heart) on the electrogenesis of the signal-averaged electrocardiogram (ECG). Two groups of asymptomatic athletes without underlying heart disease were studied: group A consisted of 35 athletes without arrhythmias and group B of 25 athletes with frequent and complex ventricular arrhythmias (ventricular ectopic beats >5000 . 24 h" ' and ventricular couplets >15.24h~'). Late potentials were present if athletes had significantly prolonged filtered QRS and low amplitude signal duration and low root mean square voltages at both 25-250 Hz and 40-250 Hz filters. While late potentials were absent in all normal athletes of group A, they were present in seven of 25 (28%) athletes with arrhythmias of group B (/ > <0003). Ten of 25 athletes (five with and five without late potentials) of group B underwent programmed ventricular stimulation using a protocol comprising up to three extrastimuli. No episode of sustained ventricular tachycardia was induced. In four of five athletes with late potentials and in one of five without them, unsustained ventricular responses were induced. Echocardiographically determined left ventricular mass found in both groups of athletes did not influence the pathological result of the signal-averaged ECG parameters.
Introduction
The prevalence and predictive value of ventricular late potentials in patients with coronary artery disease is well known' 11 . In this population, ventricular late potentials provide important prognostic information in identifying patients at risk of late arrhythmic events after acute myocardial infarction' 2 " 4 '. However, the diagnostic and prognostic role of late potentials in subjects with ventricular arrhythmias and without overt heart disease is debated' 51 . Currently, these latter arrhythmias seem to be of a benign natural course, even if some studies show conflicting results' 6 ' 71 . In the athletic population, ventricular arrhythmias in the absence of cardiac disease are not a rare finding* 8 ' 91 and, in some cases, malignant
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Correspondence: Alessandro Biffi, MD, Via Gerolamo Belloni, 112-00191, Rome, Italy. ventricular tachyarrhythmias are considered to cause sudden cardiac death' 101 . Furthermore, while the influence of hypertrophic cardiomyopathy on the signalaveraged electrocardiogram (ECG) has been studied 1 " 1 , the role of physiological cardiac hypertrophy on the electrogenesis of signal-averaged ECG parameters is not known. Therefore, these data underline the necessity for finding new, non-invasive techniques with high prognostic value, to predict the role of ventricular arrhythmias in apparently healthy subjects. The aim of this study is to assess: (1) the prevalence of ventricular late potentials in a population of apparently healthy top-level athletes (control group) and in a group of athletes with frequent and complex ventricular arrhythmias and without apparent heart disease; (2) the influence of physiological cardiac hypertrophy (athlete's heart) on signal-averaged ECG parameters; (3) the usefulness of the signalaveraged ECG as a predictor for inducible repetitive ventricular arrhythmias during an electrophysiological study.
Methods

Athletes
Sixty top-level white athletes were selected for the study overall, according to the following entry criteria: (1) normality of cardiac physical examination, laboratory tests (including thyroid evaluation), resting electrocardiogram and bicycle-exercise stress-test, chest X-ray examination, M-mode, 2D, Doppler and colour Doppler echocardiography. (2) Antiarrhythmic agents or drugs could not be taken at the time of examination. Group A consisted of 35 healthy elite athletes (35 males, mean age 24-8 years, ranging from 18 to 33 years) randomly selected from various isotonic sports, who were annually evaluated in our Institute for cardiovascular screening. Group B consisted of 25 healthy athletes (25 males, mean age 25-3 years, ranging from 17 to 30 years) of the same level of physical training and with frequent and complex ventricular arrhythmias. All athletes were selected from aerobic-isotonic sports (marathon, cross-country skiing, cycling, rowing, canoeing etc.), because these sports generally induce greater physiological myocardial hypertrophy than isometric exercise 1121 . Except for three of Group B who had palpitations, the athletes were asymptomatic.
24-hour Holier monitoring
The group A athletes were selected on the basis of the absence of cardiac arrhythmias during 24 h Holter monitoring (<10 isolated ventricular ectopic beats. 24 h ~ '). The group B athletes were selected from a larger group of 150 arrhythmic athletes, who underwent a complete cardiovascular examination, including 24 h Holter monitoring. From these 150, only the more arrhythmic subjects were selected for this study on the basis of the following Holter monitoring criteria (1) ventricular ectopic beats >5000 . 24 h~ '; (2) ventricular couplets >15.24h"'. 
Echocardiography
Signal-averaged electrocardiography (ECG)
A time-domain signal-averaged ECG was performed in all athletes of both groups. Signal averaged ECGs were recorded after careful skin preparation and the application of silver-silver chloride electrodes. The Arrhythmia Research Technology model 101 or model 1200 EPX machines were used to record orthogonal X, Y and Z leads. The signal from each lead was amplified 1000 times and converted from analog to digital form at 16-bit accuracy with a sampling rate of 1000 Hz. Ectopic or noisy beats were rejected by a recognition template generated from the first eight beats. At least 200 beats were averaged in each recording with a noise level 0-2 |iV. After signal-averaging, the data were filtered using a bidirectional digital filter with a bandpass of 25 to 250 and 40 to 250 Hz. The beginning and the end of the filtered QRS complex was determined by computer algorithm to eliminate operator bias. Three signalaveraged ECG parameters were examined and compared between athlete groups. These parameters included the filtered QRS duration, the duration of the terminal QRS or low amplitude signal <40 uV (LAS duration), the root-mean-square of the terminal 40 ms (RMS). Normal values for these parameters are considered according to the Task Force standards for analysis of ventricular late potentials 1 ' 51 . These criteria include that late potentials exist if three of the following parameters are present (using 25 Hz and 40 Hz high-pass bidirectional filtering): (1) filtered QRS complex >114 ms, (2) terminal vector magnitude complex below 40 uV for <38 ms, and (3) <25 uV (25 Hz) and <20 uV (40 Hz) of signal in the last 40 ms of the vector magnitude complex.
Programmed ventricular stimulation
Only 10 group B athletes consented to undergo right ventricular premature stimulation. Ventricular stimulation was performed using a programmable stimulator (Medtronics 5328), delivering rectangular pulses of 2 ms duration at twice the diastolic threshold. Up to three extrastimuli were introduced after eight ventricular paced beats at three drive cycle lengths (600, 500 and 400 ms) and in two right ventricular sites (apex and outflow tract). During the introduction of the third extrastimulus, coupling intervals <190 ms were not used to avoid aspecific ventricular responses' 161 .
Statistical analysis
Means ± standard deviations were determined for the clinical, signal-averaged electrocardiographic and echocardiographic results. made using Student's t-test for independent samples. The relation between signal-averaged parameters and left ventricular mass was determined by linear regression analysis.
Results
24-hour Holter monitoring
Ten of 25 group B athletes had > 10 000 ventricular ectopic beats. 24h~', nine athletes had >40 couplets. 24 h~', eight up to 15 triplets . 24 h ~ ' and four episodes of non-sustained ventricular tachycardia (4-8 beats). In 20 athletes the documented clinical arrhythmia had a left bundle branch block configuration with inferior frontal plane axis, a left bundle branch block morphology with superior frontal plane axis in two athletes and a right bundle branch block configuration in three athletes. These arrhythmias were asymptomatic in 22 athletes and three athletes symptomatic for palpitations.
Time-domain signal-averaged ECG data
Signal-averaged ECG findings of both groups are listed in Table 1 . Ventricular late potentials are absent in all normal athletes of group A, while they were present in 7/25 (28%) of the group B athletes (/><0-003). Table 1 documents that the presence of three on three anomalies at both 25 and 40-250 Hz filters on the signal-averaged ECG is the more specific and statistically significant criteria for distinguishing athletes with, from those without, arrhythmias. In fact, while the group A athletes without arrhythmias did not show the presence of any anomaly, the group B athletes with arrhythmias showed the evidence of three on three anomalies at both filters. Furthermore, our data show a significantly greater prevalence of arrhythmic athletes than controls had a prolonged QRS duration > 114 ms, <20uV of signal in the last 40 ms of the vector magnitude complex (RMS 40) and a terminal vector magnitude complex below 40 uV for >38ms (LAS). Table 1 documents that the mean values of these parameters showed a significant difference between the groups.
Correlation between signal-averaged ECG and echocardiographic data
No significant differences in left ventricular mass between the two groups of athletes and between the group B athletes with or without ventricular late potentials were found. These data show that there is no influence of the left ventricular mass on overall signal-averaged ECG Age and sex
NSVT (3) NSVT (5) NSVT (7) NSVT ( parameters in top-level athletes (Fig. 1) . The only significant linear relationship was found between left ventricular mass and filtered QRS duration in normal athletes of group A, while no correlation was observed in arrhythmic athletes of group B (Fig. 2) . It is important to underline that only 1/35 athletes of group A (2-8%) had a filtered QRS duration > 114 ms (but with a left ventricular mass <200 g), while 9/25 (36%) of group B had a prolonged QRS duration, independently of left ventricular mass. These data show that even an extreme cardiac hypertrophy (10 group A athletes had a left ventricular mass ranging from 350 up to 460 g) does not seem to influence filtered QRS duration for values greater than 114 ms in top-level athletes. Furthermore, no correlation was found also between RMS, LAS 40 and left ventricular mass in either group. Table 2 shows the electrophysiological findings of 10 arrhythmic athletes of group B (five with and five without late potentials) submitted to a programmed ventricular stimulation protocol. No episode of sustained ventricular tachycardia was induced. In four of five athletes with ventricular late potentials (3/3 criteria at both filters) and in only one of five without them, non sustained ventricular response (from six up to 25 beats) was induced. The electrically induced ventricular response always consisted of a greater number of ventricular beats than the clinical arrhythmia. S4 stimulation sequences were required for the induction of unsustained ventricular tachycardia in four of five subjects. In all cases the QRS morphology of the induced ventricular tachycardia was similar to that of the clinical arrhythmia.
Programmed ventricular stimulation
Discussion
This study provides information which may serve as a first step in evaluating non-invasive markers of arrhythmic risk, such as signal-averaged ECG, in top-level athletes with ventricular arrhythmias. The signalaveraged ECG data derived from patients after acute myocardial infarction or idiopathic dilated cardiomyopathy are not always applicable to other population subgroups. This is especially true in apparently healthy and asymptomatic subjects with or without complex ventricular arrhythmias. In fact, in these latter populations there is a lack of hard end points with which to assess the predictive value of signal-averaged ECG parameters. Few studies have been conducted on the prevalence and the predictive value of late potentials in normal subjects' 171 and none in athletes without overt heart disease. The major findings that emerge from this study are that: (a) ventricular late potentials are not found in healthy top-level athletes without arrhythmias; (b) 28% of athletes with frequent and complex ventricular arrhythmias showed late potentials; (c) cardiac hypertrophy in the athletes did not influence the signalaveraged ECG parameters; (d) the presence of ventricular late potentials is correlated to a non-sustained ventricular response during an electrophysiological test.
The studies performed so far on the prevalence of late potentials in untrained healthy subjects showed a rate of 0-10%
[l7 ' 181 . This is in contrast with our data which showed no ventricular late potentials in normal top-level athletes. This difference could relate to the non-homogeneous selection criteria used in the different studies as far as a pathological response is concerned. Raineri et al. found a correlation between the signalaveraged QRS duration and body size, particularly body height' 18 '. In another study, the same authors also showed a significant linear relationship between QRS duration and left ventricular mass' 191 . They suggested that a prolonged filtered QRS duration does not depend only on delayed, fragmented and inhomogeneous electric activity, but is also the electrocardiographic expression of a greater mass of myocardium. In this study, the expected echocardiographically determined left ventricular great mass found in normal athletes showed a significant linear relationship with signal-averaged QRS duration, but did not influence this parameter for pathological values (>114 ms). These data could be explained by the fact that myocardial hypertrophy in athletes, even if extreme, is generally a benign and physiological finding 1 ' 21 and does not seem to modify, in a pathological way, the electrophysiological factors involved in the genesis of the signal-averaged QRS duration. Interestingly, we found no difference in left ventricular mass either between athletes with and without arrhythmias or between athletes with and without late potentials. Therefore, these results indicate that other electrophysiological aspects, but not physiological hypertrophy, can alter signal-averaged ECG parameters. However, the number of subjects studied is too small to be able to draw definite negative conclusions concerning the lack of correlation with the extent of ventricular hypertrophy. Furthermore, because the two groups of athletes were of the same level of physical activity (top-level athletes), the possibility that the autonomic tone imbalance induced by training 120 ' could interfere with signal-averaged ECG was reduced.
Recently,-some authors showed the usefulness of the signal-averaged ECG in the early detection of an arrhythmogenic myocardial substrate. Solomon et a/.' 21 
'
showed that the signal-averaged ECG might contribute to non-invasive identification of patients with coronary artery disease. They demonstrated that this tool could be used as a marker to differentiate patients with from those without coronary artery disease. Vacek and Scott Smith' 22 ' documented the occurrence of transient worsening of signal-averaged ECG parameters in a marathon runner with clinical evidence of myocarditis who exercised to a high level while suffering clinical manifestation of a viremia. Mehta et a/.' 51 showed that the presence of late QRS potentials is useful in identifying those patients with spontaneous ventricular tachycardia without apparent heart disease who have a moderate increase in myocardial fibrosis on biopsy. These histological findings were consistent with nonspecific cardiomyopathy as defined by Olsen' 231 . The result of signal-averaged ECG have not been correlated with histological findings in any other studies. At present, we have not considered performing myocardial biopsies in our group of asymptomatic athletes and we sought for a further non-invasive cardiological examination that could be used more safely to improve the identification of an arrhythmogenic substrate in this selected arrhythmic population. The significantly greater prevalence of late potentials found in the group of athletes with ventricular arrhythmias shows the applicability of the signal-averaged ECG in identifying from among the arrhythmic athletes those who could have an arrhythmogenic myocardial substrate not yet detected by other non-invasive diagnostic techniques. In patients with ischaemic heart disease and ventricular tachycardia the presence of late potentials correlates with inducibility of sustained and unsustained ventricular tachycardia' 2^* '. In contrast, the sensitivity and specificity of ventricular stimulation in young patients with ventricular arrhythmias are still unknown' 161 . Metha el a/.
151 investigated the clinical utility of the signalaveraged ECG in relation to programmed electrical stimulation in patients with ventricular tachycardia and without clinical evidence of structural heart disease. They showed that all patients with late potentials had inducible ventricular tachycardia, but late potentials had a low sensitivity for predicting inducibility for both sustained and non-sustained ventricular tachycardia. In this study we performed programmed electrical stimulation in 10 out of 25 apparently healthy athletes with frequent and complex ventricular arrhythmias, but no clinical episodes of sustained ventricular tachycardia. We did not induce sustained ventricular tachycardia in any subject, but only non-repetitive responses (50% of cases). This type of response was more frequent in athletes with late potentials (4 of 5), than in athletes without them (1 of 5). Therefore, the presence of late potentials, detected by utilizing a very restricted protocol (3 on 3 parameters at both 25 and 40-250 Hz filters), seems to identify those athletes with clinically unsustained ventricular arrhythmias and no evidence of heart disease and a prolonged inducible unsustained ventricular response. Whether the greater electrical instability documented in athletes with late potentials than in those without them could be related to a subclinical stage of an arrhythmogenic myocardial substrate is yet to be demonstrated.
